Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Imprimis Pharmaceuticals | Location not on file | Makes it | Not inspected on record |
Recalls
- May 14, 2024 · Class II · Imprimis NJOF, LLC
Lack of Assurance of Sterility
Lots: Lot #: 23JUN003, Exp. Date 5/29/2024; 23JUL035, Exp. Date 7/24/2024; 23AUG033, Exp. Date 8/14/2024; 23AUG043, Exp. Date 8/21/2024; 23SEP001, Exp. Date 9/26/2024; 23OCT002, Exp. Date 10/4/2024; 23OCT031, Exp. Date 10/31/2024; 23NOV011, Exp. Date 11/28/2024; 24FEB027, Exp. Date 2/15/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Moxifloxacin: every company that makes it
- Form
- injection, solution
- Strength
- 5 mg per 1 mL
- Approval
- unapproved drug other
- On the market since
- Jan 5, 2018
- Package NDCs
71384-511-01- Official label
- DailyMed (National Library of Medicine), updated Mar 3, 2020
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?